Foley Hoag LLP represented Satellite Bio on the deal. Satellite Bio, a regenerative medicine company raised $110 million in Seed and Series A funding. The recent Series A...
Satellite Bio’s $110 Million Seed Series A Funding
Alcyone Therapeutics’ $23 million Funding Round
Foley Hoag advised Alcyone Therapeutics on the deal. Alcyone Therapeutics, a Lowell, Massachusetts-based biotechnology company pioneering next-generation precision central nervous system (CNS) therapies, closed $23 million in...